Sacral myeloid sarcoma involving multiple metastases to the brain: A case report

Experimental and Therapeutic Medicine
Sunima LamaQiyong Gong

Abstract

The presentation of myeloid sarcoma (MS) in the bone is common; however, rarely does the tumor occur in the sacral spine, and in a normal patient with no history of acute myeloid leukemia. The present study describes the rare case of a previously healthy 24-year-old male patient, who presented with a history of six months of repeated pain in the right leg and hip and limping for less than a month, who was diagnosed with sacral MS. Despite receiving surgical management and chemotherapy promptly subsequent to the diagnosis and undergoing close observation following the treatment, the patient still developed metastases to multiple sites of the brain. Taking into account the similar presentation of this rare disease to other entities, the early and accurate diagnosis of MS is vital, and the condition should be considered as a threatening manifestation with the possibility of metastasis to other sites of the body.

References

Mar 1, 1994·Radiology·M H PuiJ W Langston
Apr 4, 1998·Skeletal Radiology·S L NovickE K Fishman
Jan 24, 2002·AJR. American Journal of Roentgenology·A GuermaziE de Kerviler
Jul 14, 2005·European Journal of Pediatrics·Yusuke ShiozawaYuichiro Yamashiro
Jun 15, 2007·International Journal of Clinical Oncology·Enrico BalleariRiccardo Ghio
Mar 26, 2008·Neurologia Medico-chirurgica·Tomoo InoueTeiji Tominaga
Dec 26, 2008·International Journal of Hematology·Darko AnticLjubomir Jakovic
Jan 23, 2010·AJR. American Journal of Roentgenology·Jee Hyun SeokChoon-Choo Kim
Jun 21, 2011·Haematologica·Friedrich StölzelMarkus Schaich
Dec 12, 2012·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Darko AnticDragica Tomin
Oct 1, 2011·Therapeutic Advances in Hematology·Batia Avni, Maya Koren-Michowitz
Sep 11, 2013·Neurology·Marc C ChamberlainJames Fink

❮ Previous
Next ❯

Citations

Aug 19, 2015·The Spine Journal : Official Journal of the North American Spine Society·Yijie LiuWeimin Jiang
Sep 24, 2020·Ocular Immunology and Inflammation·Nan SunXiaomin Zhang

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
bone marrow aspiration
surgical resection

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
K J Banquer
Joint, Bone, Spine : Revue Du Rhumatisme
R Kara-TerkiX Phelip
Scandinavian Journal of Rheumatology
A PerezI Marimón
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
Gregory J Coffman
© 2021 Meta ULC. All rights reserved